Attorneys for the FTX founder have inquired about possibly administering extended-release ADHD medication to their client, citing his difficulties maintaining focus throughout the trial. In a letter dated Oct. 15, attorneys for Sam Bankman-Fried reached out to New York District…
Related Posts
Bullish patterns in Trump Coin face whale-sized risks
Trump Coin formed a bullish pattern a few months ago, but increased whale selling pressure, soaring exchange balances,…
Ethereum Pectra upgrade adds new features — How long before ETH price reacts?
Key takeaways: Reclaiming the $2,200 level remains the first price challenge for ETH. ETH price could recover if…
Arbitrum Stylus mainnet launch opens Web3 for traditional coders
Offchain Labs introduces Arbitrum Stylus on mainnet, enabling DApp development with WebAssembly languages, boosting performance, and lowering gas…